The North America Pulmonary Function Testing Market is expected to reach USD 2.47 billion by 2031 from USD 1.53 billion in 2023, growing at a CAGR of 6.1% in the forecast period of 2024 to 2031.
North America Pulmonary Function Testing Market, By Type (Hardware, Software, and Services), Patient Type (Adult, Geriatric, and Pediatric), Application (Obstructive Lung Disease and Restrictive Lung Disease), End User (Hospital, Specialty Clinics, Diagnostics Laboratories, Home Care Settings, and Others), Countries (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031 Overview of North America Pulmonary Function Testing Market Dynamics: Driver • Increasing prevalence of respiratory diseases Restraint • High cost of testing equipment Opportunity • Rapid technological advancements Market Players: The key players operating in the North America pulmonary function testing market are: • VYAIRE MEDICAL, INC. • Teleflex Incorporated • CAIRE, Inc. • COSMED srl • Schiller AG • PULMONE ADVANCED MEDICAL DEVICE • ndd Medical Technologies • KoKo PFT • ECO MEDICS • Morgan Scientific • Inofab Health • Data Sciences International • IngMar Medical • JK Medical System Pvt. Ltd • Scireq • MEDLINE • VITALOGRAPH • CONTEC MEDICAL SYSTEMS CO., LTD
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Pulmonary Function Testing Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porter’s Five Forces
4.2 Pestel Analysis
5 Regulatory Framework
6 Market Overview
6.1 Drivers
6.1.1 Increasing Prevalence Of Respiratory Diseases
6.1.2 Early Detection Of Respiratory Diseases
6.1.3 Growing Geriatric Population
6.1.4 Increasing Product Launches And Emergence Of Home Testing Devices
6.2 Restraints
6.2.1 High Cost Of Testing Equipment
6.2.2 Technological Limitation Of Testing Devices
6.3 Opportunities
6.3.1 Rapid Technological Advancements
6.3.2 Rising Strategic Initiatives
6.3.3 Government Initiatives And Reimbursement Policies
6.3.4 Product Development For At-home Testing
6.4 Challenges
6.4.1 Lack Of Standardization And Variability In Test Results
6.4.2 Lack Of Skilled Professionals
7 North America Pulmonary Function Testing Market, By Type
7.1 Overview
7.2 Hardware
7.2.1 Pft Devices
7.2.2 Pft Accessories & Consumables
7.2.2.1 Spirometry
7.2.2.2 Lung Volume In Unit/ Plethysmography Test
7.2.2.3 Gas Exchange Testing
7.2.2.4 Cardiopulmonary Exercise Test (Cpet)
7.2.2.5 Pulse Oximetry Test
7.2.2.6 Diffusion Capacity Test
7.2.2.7 Maximal Voluntary Ventilation
7.2.2.8 Oxygen Titration Test
7.2.2.9 Respiratory Muscle Function
7.2.2.10 Bronchial Provocation Test
7.2.2.11 High Altitude Simulation Testing
7.2.3 Others
7.2.3.1 3.2. Direct Tender
7.2.3.2 3.2. Retail Sales
7.2.4 Others
7.3 Software
7.4 Services
8 North America Pulmonary Function Testing Market, By Patient Type
8.1 Overview
8.2 Adult
8.2.1 Male
8.2.2 Female
8.3 Geriatric
8.3.1 Male
8.3.2 Female
8.4 Pediatric
8.4.1 Male
8.4.2 Female
9 North America Pulmonary Function Testing Market, By Application